McGuire Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
McGuire Capital Advisors's BMY Position: Q2 2026 in Review
McGuire Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 393% in Q2 2026, buying an estimated $270K and bringing the position to 5,889 shares worth $339K. The position accounts for 0.19% of the portfolio, ranked #71.
McGuire Capital Advisors first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- McGuire Capital Advisors held 5,889 shares of Bristol-Myers Squibb worth $339K as of Q2 2026.
- McGuire Capital Advisors bought 4,694 Bristol-Myers Squibb shares in Q2 2026, an estimated $270K.
- Bristol-Myers Squibb made up 0.19% of McGuire Capital Advisors's portfolio in Q2 2026, its #71 holding.
- McGuire Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.